Evidence map›Paper›PMID 41806041›Full record

ArticleCellular and molecular life sciences : CMLS2026

Emw1/TTC27 is a chaperone required for folding of the eukaryotic elongation factor 2.

Mengqi Yang, Ruixin Li, Anna I Mikolajczak, Vanessa A Wright, Mahnoor Hassan, Cara K Vaughan, Thomas A K Prescott, Jennifer A Heritz, Mehdi Mollapour, Barry Panaretou

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mengqi YangInstitute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
Ruixin LiInstitute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
Anna I MikolajczakInstitute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
Vanessa A WrightInstitute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
Mahnoor HassanInstitute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
Cara K VaughanDepartment of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA.
Thomas A K PrescottRoyal Botanic Gardens, Kew, Richmond TW9 3AB, Surrey, UK.
Jennifer A HeritzDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Mehdi MollapourDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Barry PanaretouInstitute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK. barry.panaretou@kcl.ac.uk.ORCID http://orcid.org/0000-0002-7377-4547

Funding

Regulatory mechanisms of the Hsp90 chaperone machinery.R35GM139584 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI MOLLAPOUR, MEHDI · 2021 to 2025
$2.2M
BBSRC BB/M009513/1NIGMS NIH HHS R35 GM139584NIGMS NIH HHS R35GM139584
6 · The paper itself

Abstract

Eukaryotic elongation factor 2 (eEF2) requires extensive chaperone support due to its complex multi-domain structure and high abundance. However, the full complement of chaperones involved in its folding remains elusive. Here, we identify a protein that bears TetraTriCopeptide repeats, Emw1/TTC27, as a critical chaperone for eEF2 folding. This essential protein has been conserved throughout the eukaryotic lineage. Using the budding yeast Saccharomyces cerevisiae, we show that Emw1/TTC27 physically interacts with eEF2, and levels of the elongation factor decline when activity of Emw1/TTC27 is limited. Emw1/TTC27 facilitates folding during eEF2 synthesis rather than stabilizing pre-folded eEF2. This role parallels that of Hgh1, another known eEF2 chaperone, with evidence suggesting that Emw1/TTC27 and Hgh1 cooperate, as dual impairment of these proteins severely restricts yeast growth. In the hgh1Δ background expressing a hypomorphic allele of EMW1, additional deletion of one of the two eEF2 paralogs is lethal, underscoring the essential role of Emw1/TTC27 in preventing toxic folding intermediates during eEF2 biogenesis. Taken together, our data suggest that Emw1/TTC27 is a critical addition to the eEF2 chaperone network, acting co-translationally with other chaperones to ensure eEF2 folding and maintain proteostasis.

Indexed as

Molecular ChaperonesPeptide Elongation Factor 2Saccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAmino Acid SequenceProtein BindingProtein FoldingMolecular ChaperonesPeptide Elongation Factor 2Saccharomyces cerevisiae ProteinsChaperoneProtein foldingProtein stability

Identifiers

PMID41806041
PMCPMC13049181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.